Objectives Vestibular schwannomas (VS) are intracranial tumors, which are caused by NF2 gene mutations that lead to loss of merlin protein. A treatment for VS is stereotactic radiosurgery, a form of radiation. To better understand the radiobiology of VS and radiation toxicity to adjacent structures, our main objectives were (1) investigate effects of single fraction (SF) radiation on viability, cytotoxicity, and apoptosis in normal Schwann cells (SCs) and merlin-deficient Schwann cells (MD-SCs) in vitro, and (2) analyze expression of double strand DNA breaks (γ-H2AX) and DNA repair protein Rad51 following irradiation. Study Design This is a basic science study. Setting This study is conducted in a research laboratory. Participants Patients did not participate in this study. Main Outcome Measures In irradiated normal SCs and MD-SCs (0-18 Gy), we measured (1) viability, cytotoxicity, and apoptosis using cell-based assays, and (2) percentage of cells with γ-H2AX and Rad51 on immunofluorescence. Results A high percentage of irradiated MD-SCs expressed γ-H2AX, which may explain the dose-dependent losses in viability in rodent and human cell lines. In comparison, the viabilities of normal SCs were only compromised at higher doses of radiation (>12 Gy, human SCs), which may be related to less Rad51 repair. There were no further reductions in viability in human MD-SCs beyond 9 Gy, suggesting that <9 Gy may be insufficient to initiate maximal tumor control. Conclusion The MD-SCs are more susceptible to radiation than normal SCs, in part through differential expression of γ-H2AX and Rad51. Understanding the radiobiology of MD-SCs and normal SCs is important for optimizing radiation protocols to maximize tumor control while limiting radiation toxicity in VS patients.
|Number of pages||9|
|Journal||Journal of Neurological Surgery, Part B: Skull Base|
|State||Published - Jun 1 2022|
Bibliographical noteFunding Information:
American Hearing Research Foundation Bernard & Lottie Drazin Memorial Grant to Dr. Erin Cohen and the North American Skull Base Society Research Grant to Drs.
Telischi, Dinh, and Ivan. Normal SC cultures were prepared in the laboratory of Paula Monje, in part funded by the Craig H. Neilsen Foundation, U.S. Department of Health and Human Services, National Institutes of Health (grant 339576). The merlin-deficient Schwann cells were prepared in the laboratory of Cristina Fernandez-Valle, National Institute on Deafness and Other Communication Disorders and in part funded by the NIH/NIDCD 1R01-DC010189-06.
© 2022 Thieme Medical Publishers, Inc.. All rights reserved.
- DNA damage
- DNA repair
- Schwann cells
- vestibular schwannoma
ASJC Scopus subject areas
- Clinical Neurology